Missing clinical trial data: the knowledge gap in the safety of potential COVID-19 drugs
View ORCID ProfileFlorence Rodgers, Toby Pepperrell, View ORCID ProfileSarai Keestra, Victoria Pilkington
doi: https://doi.org/10.1101/2020.05.30.20117523
Florence Rodgers
1School of Medicine, Imperial College London, London, UK
Toby Pepperrell
1School of Medicine, Imperial College London, London, UK
Sarai Keestra
2School of Anthropology & Museum Ethnography, University of Oxford, UK
3Department of Global Health & Development, London School of Hygiene and Tropical Medicine, UK
Victoria Pilkington
4St Mary’s Hospital, Imperial College Healthcare NHS Trust, UK
Article usage
Posted June 04, 2020.
Missing clinical trial data: the knowledge gap in the safety of potential COVID-19 drugs
Florence Rodgers, Toby Pepperrell, Sarai Keestra, Victoria Pilkington
medRxiv 2020.05.30.20117523; doi: https://doi.org/10.1101/2020.05.30.20117523
Subject Area
Subject Areas
- Addiction Medicine (317)
- Allergy and Immunology (621)
- Anesthesia (162)
- Cardiovascular Medicine (2317)
- Dermatology (205)
- Emergency Medicine (373)
- Epidemiology (11650)
- Forensic Medicine (10)
- Gastroenterology (687)
- Genetic and Genomic Medicine (3654)
- Geriatric Medicine (343)
- Health Economics (625)
- Health Informatics (2340)
- Health Policy (922)
- Hematology (337)
- HIV/AIDS (765)
- Medical Education (362)
- Medical Ethics (102)
- Nephrology (394)
- Neurology (3406)
- Nursing (193)
- Nutrition (512)
- Oncology (1787)
- Ophthalmology (529)
- Orthopedics (212)
- Otolaryngology (284)
- Pain Medicine (227)
- Palliative Medicine (66)
- Pathology (441)
- Pediatrics (1014)
- Primary Care Research (411)
- Public and Global Health (6046)
- Radiology and Imaging (1243)
- Respiratory Medicine (816)
- Rheumatology (373)
- Sports Medicine (319)
- Surgery (391)
- Toxicology (50)
- Transplantation (171)
- Urology (144)